Krista M. Isaac

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson et al. · Haematologica · 2018 · 452 citations · Full text

Medicine, Oncology, Pharmacology +12

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 318 citations · Full text

Pharmacy, Health Sciences, Internal Medicine +3

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

Anthony R. Mato, Brian T. Hill, Nicole Lamanna et al. · Annals of Oncology · 2017 · 224 citations · Full text

Medicine, Hematology, Oncology +16

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States

Anthony R. Mato, Meghan C. Thompson, John N. Allan et al. · Haematologica · 2018 · 165 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib

Allison Winter, Daniel J. Landsburg, Anthony R. Mato et al. · Blood · 2017 · 34 citations · Full text

Medicine, Pharmacotherapy, Outcomes Research +9